Non-invasive imaging techniques as positron emission tomography (PET), single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), computed tomography (CT) and optical imaging have been indispensable for early diagnosis, in monitoring disease progression and therapeutic of a wide range of pathologies in both the laboratory and clinic. Therefore, molecular imaging methods provide accurate information on pathophysiological changes underlying neurological diseases and also cancer. Abraham Martin’s lab focuses his research around experimental stroke using molecular imaging technology. The purpose of his research is to visualize and quantify biological processes (i) during acute phase of ischemic stroke as enzyme activity, cell death, inflammation at the cellular/molecular level and (ii) affecting sub-acute phases as angiogenesis and brain function recovery.
Abraham Martín Muñoz
Research AssociatePersonal data